Lipocine
LPCN
LPCN
37 hedge funds and large institutions have $18.6M invested in Lipocine in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
74% less call options, than puts
Call options by funds: $451K | Put options by funds: $1.72M
Holders
37
Holding in Top 10
–
Calls
$451K
Puts
$1.72M
Top Buyers
| 1 | +$908K | |
| 2 | +$871K | |
| 3 | +$527K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$477K |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$397K |
Top Sellers
| 1 | -$2.98M | |
| 2 | -$1.33M | |
| 3 | -$397K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$330K |
| 5 |
Goldman Sachs
New York
|
-$300K |